MedTrace Logo

Relief of Migraine Pain Through Electro Stimulation

NCT02453399 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 87

Last updated 2017-12-08

No results posted yet for this study

Summary

This study will evaluate transcutaneous electro stimulation device developed by Siano for adequacy, safety and efficacy for the treatment and/or prevention of migraine pain for migraine sufferers.

Conditions

  • Migraine Headache

Interventions

DEVICE

Randomized treatment/placebo delivery of transcutaneous electro stimulation via a dedicated device Avital.

Transcutaneous electro stimulation

Sponsors & Collaborators

  • Theranica

    lead INDUSTRY

Principal Investigators

  • David Yarnitsky, MD · Rambam Health Care Campus

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-04-30
Completion
2016-05-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02453399 on ClinicalTrials.gov